Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
Martinelli G, Ottaviani E, Buonamici S, Isidori A, Borsaru G, Visani G, Piccaluga PP, Malagola M, Testoni N, Rondoni M, Nucifora G, Tura S, Baccarani M. Martinelli G, et al. Among authors: buonamici s. Haematologica. 2003 Nov;88(11):1221-8. Haematologica. 2003. PMID: 14607750
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation.
Martinelli G, Terragna C, Zamagni E, Ronconi S, Tosi P, Lemoli R, Bandini G, Testoni N, Amabile M, Ottaviani E, Buonamici S, Soverini S, Montefusco V, de Vivo A, Bonifazi F, Tura S, Cavo M. Martinelli G, et al. Among authors: buonamici s. Haematologica. 2000 Sep;85(9):930-4. Haematologica. 2000. PMID: 10980631
Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
Visani G, Buonamici S, Malagola M, Isidori A, Piccaluga PP, Martinelli G, Ottaviani E, Grafone T, Baccarani M, Tura S. Visani G, et al. Among authors: buonamici s. Leukemia. 2001 Nov;15(11):1696-700. doi: 10.1038/sj.leu.2402266. Leukemia. 2001. PMID: 11681409 Clinical Trial.
Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
Buonamici S, Ottaviani E, Testoni N, Montefusco V, Visani G, Bonifazi F, Amabile M, Terragna C, Ruggeri D, Piccaluga PP, Isidori A, Malagola M, Baccarani M, Tura S, Martinelli G. Buonamici S, et al. Blood. 2002 Jan 15;99(2):443-9. doi: 10.1182/blood.v99.2.443. Blood. 2002. PMID: 11781223 Free article.
Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely.
Martinelli G, Buonamici S, Visani G, Malagola M, Piccaluga PP, Isidori A, Bosi C, Bonifazi F, Soverini S, Terragna C, Amabile M, Giannini B, Baccarani M. Martinelli G, et al. Among authors: buonamici s. Leukemia. 2003 Mar;17(3):650-1; author reply 651-2. doi: 10.1038/sj.leu.2402822. Leukemia. 2003. PMID: 12646962 No abstract available.
P/CAF and GCN5 acetylate the AML1/MDS1/EVI1 fusion oncoprotein.
Senyuk V, Sinha KK, Chakraborty S, Buonamici S, Nucifora G. Senyuk V, et al. Among authors: buonamici s. Biochem Biophys Res Commun. 2003 Aug 8;307(4):980-6. doi: 10.1016/s0006-291x(03)01288-9. Biochem Biophys Res Commun. 2003. PMID: 12878208
The role of EVI1 in normal and leukemic cells.
Buonamici S, Chakraborty S, Senyuk V, Nucifora G. Buonamici S, et al. Blood Cells Mol Dis. 2003 Sep-Oct;31(2):206-12. doi: 10.1016/s1079-9796(03)00159-1. Blood Cells Mol Dis. 2003. PMID: 12972028 Review.
62 results